Fizjosanat Sp. z o.o. (Poland)

Main Activities: Pharmacies and Drug Stores

Secondary Activities: Electronics and Appliance Stores | Other Direct Selling Establishments | Lessors of Real Estate | Rental and Leasing Services | Other Commercial and Industrial Machinery and Equipment Rental and Leasing | Computer Systems Design and Related Services | Administrative Management and General Management Consulting Services | All Other Miscellaneous Schools and Instruction | Offices of Physicians

Full name: Fizjosanat Sp. z o.o.

Profile Updated: May 19, 2024

Fizjosanat Sp. z o.o. is based in Poland, with the head office in Warsaw. It operates in the Pharmacies and Drug Stores industry. Fizjosanat Sp. z o.o. was incorporated on October 12, 2021. The latest financial highlights indicate a net sales revenue increase of 18.1% in 2024. There was a total negative growth of 6.84% in Fizjosanat Sp. z o.o.’s total assets over the same period.

Headquarters
Ul. Mazowiecka 11/45
Warsaw; Mazowieckie; Postal Code: 00-052

Contact Details: Purchase the Fizjosanat Sp. z o.o. report to view the information.

Basic Information

Registered Capital:

Purchase the Fizjosanat Sp. z o.o. report to view the information.

Financial Auditors:

Purchase the Fizjosanat Sp. z o.o. report to view the information.

Incorporation Date:

October 12, 2021

Key Executives

Purchase this report to view the information.

President

Ownership Details

Purchase this report to view the information.

46%

Purchase this report to view the information.

34%

Purchase this report to view the information.

20%

Company Performance

Financial values in the chart are available after Fizjosanat Sp. z o.o. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.

Net sales revenue

18.1%▲

Total operating revenue

18.1%▲

Operating profit (EBIT)

N/A

EBITDA

N/A

Net Profit (Loss) for the Period

N/A

Total Assets

-6.84%▼

Total Equity

42.09%▲

Operating Profit Margin (ROS)

N/A

Net Profit Margin

N/A

Return on Equity (ROE)

N/A

Similar companies